It is indicated for treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in patients who are not controlled on existing therapy. In combination with the following oral antidiabetics or basal insulin
INJ ECTABLE, S.C.; the starting dose is 10 mcg (µg) LIXISENATIDE once daily for 14 days. Then, the LIXISENATIDE dose should be increased to 20 mcg once daily, which is the maintenance dose.
Hypersensitivity; hypoglycemic episodes
Paediatric: Safety and efficacy in pediatric patients have not been established Pregnancy: Data not sufficient; not to be used Lactation: Data not sufficient; not to be used Elderly: No dose adjustment is required based on age.
hypoglycemia, allergic reactions, nausea, nasopharyngitis, diarrhea, upper respiratory tract infection, headache
along with other glucose lowering drugs, adrenergic drugs